287 related articles for article (PubMed ID: 10544851)
1. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis.
Ravelli A; Migliavacca D; Viola S; Ruperto N; Pistorio A; Martini A
Clin Exp Rheumatol; 1999; 17(5):625-7. PubMed ID: 10544851
[TBL] [Abstract][Full Text] [Related]
2. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
3. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
van Ede AE; Laan RF; Rood MJ; Huizinga TW; van de Laar MA; van Denderen CJ; Westgeest TA; Romme TC; de Rooij DJ; Jacobs MJ; de Boo TM; van der Wilt GJ; Severens JL; Hartman M; Krabbe PF; Dijkmans BA; Breedveld FC; van de Putte LB
Arthritis Rheum; 2001 Jul; 44(7):1515-24. PubMed ID: 11465701
[TBL] [Abstract][Full Text] [Related]
4. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
[TBL] [Abstract][Full Text] [Related]
5. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study.
Huemer M; Födinger M; Huemer C; Sailer-Höck M; Falger J; Rettenbacher A; Bernecker M; Artacker G; Kenzian H; Lang T; Stöckler-Ipsiroglu S
Clin Exp Rheumatol; 2003; 21(2):249-55. PubMed ID: 12747286
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.
Ortiz Z; Shea B; Suarez-Almazor ME; Moher D; Wells GA; Tugwell P
J Rheumatol; 1998 Jan; 25(1):36-43. PubMed ID: 9458200
[TBL] [Abstract][Full Text] [Related]
9. Folinic acid protects against suppression of growth by methotrexate in mice.
Iqbal MP; Sultana F; Mehboobali N; Pervez S
Biopharm Drug Dispos; 2001 May; 22(4):169-78. PubMed ID: 11745919
[TBL] [Abstract][Full Text] [Related]
10. Effect of methotrexate and folinic acid on skeletal growth in mice.
Iqbal MP; Ahmed M; Umer M; Mehboobali N; Qureshi AA
Acta Paediatr; 2003 Dec; 92(12):1438-44. PubMed ID: 14971796
[TBL] [Abstract][Full Text] [Related]
11. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
[TBL] [Abstract][Full Text] [Related]
12. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
[TBL] [Abstract][Full Text] [Related]
13. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
Buckley LM; Vacek PM; Cooper SM
J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
[TBL] [Abstract][Full Text] [Related]
14. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
Chang CY; Meyer RM; Reiff AO
Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
[TBL] [Abstract][Full Text] [Related]
15. Folate usage in MTX-treated juvenile idiopathic arthritis (JIA) patients is inconsistent and highly variable.
Amarilyo G; Rullo OJ; McCurdy DK; Woo JM; Furst DE
Rheumatol Int; 2013 Sep; 33(9):2437-40. PubMed ID: 23400770
[TBL] [Abstract][Full Text] [Related]
16. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of folinic acid on low-dose methotrexate genotoxicity.
Shahin AA; Ismail MM; Saleh AM; Moustafa HA; Aboul-Ella AA; Gabr HM
Z Rheumatol; 2001 Apr; 60(2):63-8. PubMed ID: 11383050
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
[TBL] [Abstract][Full Text] [Related]
19. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study.
Yassin NA; Haroon M; Elhamshary A
Curr Rheumatol Rev; 2021; 17(2):242-246. PubMed ID: 33308133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
